Like its predecessors in this annual series, offers critical reviews of recent major developments in pharmacology of anti-cancer agents, the area of biologicals, and clinical management of the cancer patient. Nine contributions in the first section discuss drugs antimetabolites, alkylating agents, bleomycin, mitomycins, taxanes, DNA topoisomerase inhibitors, cisplatin, and multidrug resistance. The following seven contributions discuss biological response modifiers monoclonal antibody therapy, cytokines and immunological monitoring, adoptive immunotherapy, gene therapy, hematopoietic growth factors, reference databases of cytokine structure and function. The third section comprises 14 contributions on various kinds of tumors. Annotation c. by Book News, Inc., Portland, Or.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
EUR 15,25 per la spedizione da U.S.A. a Italia
Destinazione, tempi e costiDa: Bookmonger.Ltd, HILLSIDE, NJ, U.S.A.
Hardcover. Condizione: Good. Codice articolo mon0000431053
Quantità: 1 disponibili
Da: Bookmonger.Ltd, HILLSIDE, NJ, U.S.A.
Hardcover. Condizione: Fine. Codice articolo mon0000409629
Quantità: 3 disponibili
Da: Ammareal, Morangis, Francia
Hardcover. Condizione: Très bon. Ancien livre de bibliothèque. Salissures sur la tranche. Edition 1996. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Stains on the edge. Edition 1996. Ammareal gives back up to 15% of this item's net price to charity organizations. Codice articolo D-672-882
Quantità: 1 disponibili